Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

MDV

Medivation (MDV)

Medivation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:MDV
FechaHoraFuenteTítuloSímboloCompañía
20/03/200707:30PR Newswire (US)Medivation Common Stock Begins Trading on Nasdaq Global Market Under the Symbol 'MDVN'AMEX:MDV
19/03/200708:00PR Newswire (US)Medivation Announces Presentation of Full Top-Line Data From Dimebon(TM) Six-Month Trial at Major International Alzheimer's DiseAMEX:MDVMedivation
15/03/200711:01Business WireDutton Associates Announces Investment Opinion: Medivation Strong Speculative Buy Rating In Update Coverage By Dutton AssociatesAMEX:MDVMedivation
08/03/200715:00PR Newswire (US)Medivation Common Stock Approved for Listing on the Nasdaq Global MarketAMEX:MDVMedivation
05/03/200707:00PR Newswire (US)Medivation to Present at Cowen and Company's 27th Annual Healthcare ConferenceAMEX:MDVMedivation
26/02/200707:00PR Newswire (US)Medivation's MDV3100 Shown to Be Effective in a Preclinical Model of Hormone-Refractory Prostate CancerAMEX:MDVMedivation
16/02/200707:00PR Newswire (US)Preclinical Efficacy Data on Medivation's MDV3100 to Be Presented at ASCO-sponsored Prostate Cancer SymposiumAMEX:MDVMedivation
05/02/200707:00PR Newswire (US)Medivation to Present at BIO CEO & Investor Conference 2007AMEX:MDVMedivation
30/01/200707:00PR Newswire (US)Medivation's Dimebon(TM) Phase 2 Trial Results to be Presented at 8th International Conference on Alzheimer's and Parkinson's DiAMEX:MDVMedivation
17/01/200707:00PR Newswire (US)Medivation Names Lisa Taylor Vice President of Commercial DevelopmentAMEX:MDVMedivation
06/12/200611:00Business WireDutton Associates Announces Investment Opinion: Medivation Strong Speculative Buy Rating in Update Coverage by Dutton AssociatesAMEX:MDVMedivation
05/12/200607:00PR Newswire (US)Medivation Appoints Sue Wollowitz, Ph.D., Vice President of Chemistry and ManufacturingAMEX:MDVMedivation
04/12/200613:25PR Newswire (US)Medivation, Inc. Adopts Shareholder Rights PlanAMEX:MDVMedivation
15/11/200607:30PR Newswire (US)Medivation Provides Clinical Development Update for Its Three ProgramsAMEX:MDVMedivation
08/11/200615:00PR Newswire (US)Medivation to Host Conference Call on November 15 to Provide Clinical Development Update for Lead Product Candidate Dimebon(TM)AMEX:MDVMedivation
01/11/200607:00PR Newswire (US)Medivation Announces Participation in Rodman & Renshaw 8th Annual Healthcare ConferenceAMEX:MDVMedivation
19/10/200608:00PR Newswire (US)Medivation Begins Phase 1-2a Trial of Dimebon(TM) in Huntington's DiseaseAMEX:MDVMedivation
16/10/200608:00PR Newswire (US)Medivation to Present Additional Alzheimer's Disease Data at BIO Investor Forum 2006AMEX:MDVMedivation
28/09/200603:00Business WireMedivation Receives FDA Permission to Begin Dimebon Huntington's Disease TrialAMEX:MDVMedivation
21/09/200606:00Business WireMedivation's Dimebon Meets All Five Efficacy Endpoints in Phase 2 Alzheimer's Disease Study; Conference Call Begins at 1:00 P.M.AMEX:MDVMedivation
14/09/200615:05Business WireMedivation Appoints Dr. Andrew A. Protter Vice President of Preclinical DevelopmentAMEX:MDVMedivation
23/08/200611:00Business WireDutton Associates Announces Investment Opinion: Medivation Strong Speculative Buy Rating In Update Coverage By Dutton AssociateAMEX:MDVMedivation
17/07/200603:00Business WireTony Vernon Joins Medivation's Board of DirectorsAMEX:MDVMedivation
15/06/200611:23PR Newswire (US)Emerging Growth Equities, Ltd. Initiates Coverage of Medivation, Inc. (Amex: MDV) With a BUY RatingAMEX:MDV
23/05/200603:00Business WireMedivation to Present at the Dutton Associates' ``Recognizing Opportunity'' Health Sciences Small Cap ConferenceAMEX:MDVMedivation
16/05/200615:38Business WireMedivation Announces $14.25 Million Registered Direct OfferingAMEX:MDVMedivation
10/05/200615:07Business WireMedivation Provides Update on Huntington's Disease INDAMEX:MDVMedivation
08/05/200615:05Business WireMedivation to Present at the Rodman & Renshaw 3rd Annual Global Healthcare ConferenceAMEX:MDVMedivation
04/05/200611:00Business WireDutton Associates Announces Investment Opinion: Medivation Strong Speculative Buy Rating in Initiating Coverage by Dutton AssocAMEX:MDVMedivation
15/03/200609:35PR Newswire (US)American Stock Exchange Lists Common Stock Of Medivation IncorporatedAMEX:MDV
 Showing the most relevant articles for your search:AMEX:MDV